r TTPH Stock Quote - Tetraphase Pharmaceuticals, Inc. Stock Price Today
TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds

Tetraphase Pharmaceuticals, Inc.
(NASDAQ : TTPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.44%165.230.4%$241.40m
VRXValeant Pharmaceuticals International, Inc.
0.07%22.2414.1%$211.47m
PRGOPerrigo Co. Plc
0.16%75.236.7%$103.69m
JAZZJazz Pharmaceuticals Plc
0.88%165.022.2%$91.57m
PTLAPortola Pharmaceuticals, Inc.
2.15%40.877.7%$78.12m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.71%161.107.6%$64.33m
SAGESAGE Therapeutics, Inc.
-1.80%155.339.6%$58.04m
MNKMallinckrodt Plc
0.37%16.5021.1%$57.03m
SUPNSupernus Pharmaceuticals, Inc.
2.88%57.256.3%$49.76m
PBHPrestige Brands Holdings, Inc.
2.21%34.653.8%$41.14m
UTHRUnited Therapeutics Corporation
-1.08%103.6014.4%$36.56m
HZNPHorizon Pharma plc
4.19%16.177.5%$33.22m
CTLTCatalent Inc
0.13%38.862.6%$31.43m
ICPTIntercept Pharmaceuticals, Inc.
1.88%71.0721.8%$30.30m
ENDPEndo International Plc
0.80%6.318.9%$29.81m

Company Profile

Tetraphase Pharmaceuticals, Inc. engages in the development and production of novel antibiotics for serious and life-threatening bacterial infections. It is currently developing a product candidate, eravacycline, a fully synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.